Zobrazeno 1 - 10
of 134
pro vyhledávání: '"L W, Brady"'
Autor:
T H, Wasserman, T L, Phillips, G E, Hanks, S E, Order, C A, Perez, T F, Pajak, E, Pakuris, L W, Brady, S A, Leibel, J D, Cox
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 20:1383-1391
This paper provides an introduction into the clinical activities of the RTOG (Radiation Therapy Oncology Group), its goals, its organization, its format for protocol development, and presents major areas of achievement. It provides an organizational
Publikováno v:
American Journal of Clinical Oncology. 21:291-293
Twenty-two patients who had failed conventional treatment for advanced colorectal carcinoma metastatic to the liver were entered in this study. Survival from the date the hepatic disease was documented and ranged from 3 to 62 months, with an average
Publikováno v:
Frontiers of radiation therapy and oncology. 35
Publikováno v:
Frontiers of radiation therapy and oncology. 35
Publikováno v:
Frontiers of radiation therapy and oncology. 35
Publikováno v:
Archives of ophthalmology (Chicago, Ill. : 1960). 118(9)
To identify clinical predictive factors for visual outcome in a large series of patients who underwent plaque radiotherapy for uveal melanoma.Clinical factors, including patient data, tumor features, and radiation variables, were analyzed for their i
Autor:
L W, Brady, S H, Levitt
Publikováno v:
Rays. 24(3)
Major changes have occurred in the last 25 years which have impacted significantly on the practice of radiation oncology. Twenty-five years ago, less than 40% of all patients had radiation therapy as a part of their management either for cure, pallia
Publikováno v:
American journal of ophthalmology. 127(5)
To determine the outcome of plaque radiotherapy in the treatment of macular choroidal melanoma and to identify the risk factors associated with the development of radiation complications, tumor recurrence, and metastasis.Chart analysis of 630 consecu
Autor:
L W, Brady
Publikováno v:
Bulletin et memoires de l'Academie royale de medecine de Belgique. 153(5-6)
The data confirmed the fact that repeated administrations of iodine-125 labeled anti-epidermal growth factor receptor 425 is safe and may have benefited the management of primary high grade gliomas of the brain as well as recurrent astrocytomas. At p